Enhancing Adipose Thermogenesis Through EpFA Stabilization: Functional Evaluation of the sEH Inhibitor (t-AUCB) and 17,18-EEQ analogs TZ-1 and OMT-28
Date Issued
May 2026
Author(s)
Wu, Haoying
The University of Tennessee
Advisor(s)
Ling Zhao
Additional Advisor(s)
Jiangang Chen
Ahmed Bettaieb
Abstract
Obesity, a major global health challenge, is strongly associated with insulin resistance, type 2 diabetes, cardiovascular disease, and fatty liver disease. Current therapies have limited ability to safely increase energy expenditure, highlighting the need for strategies that enhance brown and beige adipose thermogenesis. Epoxy fatty acids (EpFAs), particularly the eicosapentaenoic acid-derived metabolite 17,18-epoxyeicosatetraenoic acid (17,18-EEQ), have emerged as potent modulators of adipocyte thermogenic programs and metabolic health. However, their therapeutic potentials are limited by rapid degradation through soluble epoxide hydrolase and other metabolic pathways, resulting in a short half-life and low bioavailability. Therefore, this dissertation investigated whether stabilizing EpFA pathway through pharmacological inhibition of sEH or through chemically and metabolically stabilized 17,18-EEQ analogs could enhance the development and function of thermogenic adipocytes of murine and human origins.vTo address this question, three complementary studies were conducted. First, the translational relevance of EpFA stabilization was examined in vivo using human brown adipocytes pretreated with the sEH inhibitor t-AUCB, then transplanted into diet-induced obese nude mice. Second, stable 17,18-EEQ analog TZ-1 was examined in murine brown preadipocytes and human adipose-derived stromal cells to determine its effects on brown adipogenesis and browning. Third, a second 17,18-EEQ analog, OMT-28, was studied in murine brown adipocytes to assess its effects on differentiation, thermogenic protein expression, mitochondrial respiration, and the involvement of PPAR signaling.
The results showed that stabilizing EpFA signaling enhanced thermogenic adipocyte function across multiple cell models. Pretreatment of human brown adipocytes with t-AUCB improved adipose tissue phenotypes in obese recipient mice, as reflected by reduced epididymal adipocyte hypertrophy, increased thermogenic and fatty acid oxidation proteins in interscapular brown adipose tissue, and reduced inflammatory NFκB signaling. In cell-based studies, TZ-1 promoted murine brown adipocyte differentiation, increased thermogenic protein expression, and enhanced browning-related markers in human adipose-derived stromal cells. OMT-28 also promoted brown adipogenesis, increased mitochondrial respiration, and upregulated thermogenic and adipogenic proteins. Mechanistic studies showed that OMT-28 activated PPARγ and PPARα reporter activity and that loss of PPARγ attenuated its adipogenic effects. Together, these findings support EpFA stabilization as a mechanistic and translational strategy to enhance thermogenic activation and improve metabolic health in obesity.
Degree
Doctor of Philosophy
Major
Biomedical nutrition science
Embargo Date
May 1, 2027